James F. Companion

Schrader BYRD & Companion PLLCLocal

General

Experience17 yrs

Elite Ratings

--

Practice Areas

Chemical Biotech (4 cases)

Biotech (71 cases)

Chemical (4 cases)

Comp. Arch. and Software (2 cases)

Communications (3 cases)

Law Firms

Schrader BYRD & Companion PLLC

--

schraderlaw.com

Ratings

Experience

Grade

Trend

DCT

L1

C

PTAB

--

--

--

CAFC

--

--

--

Cases

Case #	Court	Caption	Filed	Represent
1:24-CV-00067	N.D. WV	Novo Nordisk Inc v. Mylan Pharma Inc	07/02/24	Patent Owner :Novo Nordisk As	.
1:23-CV-00013	N.D. WV	Novo Nordisk Inc v. Viatris Inc	01/27/23	Patent Owner :Novo Nordisk As	.
1:22-CV-01040	D. DE	Novo Nordisk Inc v. Mylan Pharma Inc	08/08/22	Patent Owner(L) :Novo Nordisk As	.
1:22-MD-03038	D. DE	In re: Ozempic (Semaglutide) Patent Litigation	08/05/22	Patent Owner(L) :Novo Nordisk As	.
1:22-CV-00035	N.D. WV	AstraZeneca Ab v. Mylan Pharma Inc	04/26/22	Patent Owner(W) :Astrazeneca Ab	.
1:22-CV-00451	D. DE	Novartis Pharma Corp v. Mylan Pharma Inc	04/05/22	Patent Owner :Novartis Pharmaceuticals Corp	.
1:22-CV-00023	N.D. WV	Novo Nordisk v. Mylan	03/18/22	Patent Owner :Novo Nordisk As	.
1:21-CV-00146	N.D. WV	Novartis Pharma Corp v. Mylan Pharma Inc	12/20/21	Patent Owner :Novartis Pharmaceuticals Corp	.
1:21-CV-00839	D. DE	PF Prism Imb BV v. Mylan Pharma Inc	06/09/21	Patent Owner :PF Prism Imb BV	.
1:20-CV-00244	N.D. WV	Pfizer Inc v. Mylan Pharma Inc	10/16/20	Patent Owner :PF Prism Imb BV	.

Ratings Trends

Practice Areas